Learn More
Medchemexpress LLC 2-Heptenoic acid, 7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-me... | 1542132-88-6 | 100.0% | 528.60 | 5 MG

Supplier: Medchemexpress LLC HY193595MG
Vilagletistat (ZED-1227) is a specific and orally active transglutaminase 2 (TG2) inhibitor, with an IC50 of 45 nM. It effectively blocks inflammation-induced TG2 expression and activity, making it suitable for research into celiac disease (CeD).
- Specific and orally active TG2 inhibitor
- IC50 of 45 nM against TG2
- Blocks inflammation-induced TG2 expression and activity
- Suitable for research of celiac disease (CeD)
- Shows no cytotoxic activity in Huh7 and CaCo2 cells
- Inhibits TG2 in small intestinal mucosa both in vitro and in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.